Urinary frequency, enuresis and incontinence
Drug Safety Update
October 2015: Mirabegron (Betmiga▼): risk of severe hypertension and associated cerebrovascular and cardiac events
December 2014: Botulinum toxin products: rare but serious risks
NICE Guidance (also see drug-specific links below)
CG97: Lower urinary tract symptoms in men: management, June 2015
NG123: Urinary incontinence and pelvic organ prolapse in women: management, updated June 2019
CG148: Urinary incontinence in neurological disease: assessment and management,
TA290: Mirabegron for treating symptoms of overactive bladder, June 2013
Local Guidance
See here for local primary care guidance on the management of OAB in women
Vibegron can be prescribed second line in accordance with NICE TA999 for treating the symptoms of overactive bladder syndrome. The Kent and Medway pathway of care will be updated in due course.
| Pack |
|---|
| 30 tablet (3 x 10 tablets) |
| Pack |
|---|
| 30 tablet (3 x 10 tablets) |
| Pack |
|---|
| 28 tablet (2 x 14 tablets) |
| Pack |
|---|
| 28 tablet (2 x 14 tablets) |
| Pack |
|---|
| 56 capsule |
| 28 capsule |
| Pack |
|---|
| 56 capsule |
| Pack |
|---|
| 28 tablet (4 x 7 tablets) |
| Pack |
|---|
| 28 tablet (4 x 7 tablets) |
| Pack |
|---|
| 30 tablet (3 x 10 tablets) |
| Pack |
|---|
| 30 tablet (3 x 10 tablets) |
| Pack |
|---|
| 56 tablet (4 x 14 tablets) |
| Pack |
|---|
| 56 tablet (4 x 14 tablets) |
| Pack |
|---|
| 28 capsule (2 x 14 capsules) |
| Pack |
|---|
| 60 tablet |
| Pack |
|---|
| 28 capsule |
| 30 capsule |
| 100 capsule |
Not for use in the frail/elderly patient
| Pack |
|---|
| 56 tablet (8 x 7 tablets) |
| 84 tablet (12 x 7 tablets) |
| Pack |
|---|
| 56 tablet |
| Pack |
|---|
| 56 tablet (8 x 7 tablets) |
| Pack |
|---|
| 30 tablet |
| Pack |
|---|
| 30 tablet |
| Pack |
|---|
| 8 patch |
| Pack |
|---|
| 150 ml |
| Pack |
|---|
| 150 ml |
Caution: Due to unit differences in the potency assay, unit doses for different brands of Botulinum A toxin are NOT interchangeable.
| Pack |
|---|
| 1 vial |
| 2 vial |
| 6 vial |
| Pack |
|---|
| 1 vial |
| 2 vial |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary